Impact of fractionated stereotactic radiotherapy on activity of daily living and performance status in progressive/recurrent glioblastoma: a retrospective study.
Fiche publication
Date publication
décembre 2022
Journal
Radiation oncology (London, England)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr TAILLANDIER Luc, Dr RECH Fabien, Dr DEMOGEOT Nadine
Tous les auteurs :
Demogeot N, Salleron J, Rech F, Taillandier L, Royer P, Vogin G
Lien Pubmed
Résumé
The prognosis of recurrent glioblastoma (GBM) is poor, with limited options of palliative localized or systemic treatments. Survival can be improved by a second localized treatment; however, it is not currently possible to identify which patients would benefit from this approach. This study aims to evaluate which factors lead to a lower Karnofsky performance status (KPS) score after fractionated stereotactic RT (fSRT).
Mots clés
Cyberknife, Glioblastoma, Karnofsky performance status, Recurrence, Stereotactic radiotherapy
Référence
Radiat Oncol. 2022 12 6;17(1):201